Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.000
0.00 (0.00%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $18.57 million as of October 31, 2025. Its market cap has increased by 16.61% in one year.
Market Cap
18.57M
Enterprise Value
114.16M
1-Year Change
16.61%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $18.57M, a decrease of -58.58%. That is a compound annual growth rate of -3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 18.57M | 21.05% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | 79.64M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |